FDA's Label Directive Pumps Up Plaintiffs In Drug Suits

Law360, New York (February 6, 2013, 9:22 PM EST) -- The U.S. Food and Drug Administration might have unwittingly handed plaintiffs an attractive new weapon in failure-to-warn litigation against drugmakers when it revealed Tuesday that most prescription drugs do not adhere to the format changes laid out in a 2006 labeling rule, attorneys say.

In a notice, the FDA told drugmakers it would help them convert their product labels to the format in the so-called physician labeling rule — a 2006 regulation designed to make drug warnings easier for physicians to read and focus labels on...
To view the full article, register now.